Multicenter prospective surveillance of oral Candida dubliniensis among adult Brazilian human immunodeficiency virus-positive and AIDS patients

Diagnostic Microbiology and Infectious Disease

Volumn 41, Issue 1-2, 2001, Pages 29-35

  Milan, Eveline Pípolo ^a,b   De Laet Sant’ana, Priscilla ^a   De Azevedo Melo, Analy Salles ^a   Sullivan, Derek J ^c   Coleman, David C ^c   Lewi, David ^a   Lopes Colombo, Arnaldo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

AIDS; Candida dubliniensis; Emerging pathogen; Oral candidosis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; BRAZIL; CANDIDA DUBLINIENSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FUNGUS GROWTH; HEALTH CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; TEMPERATURE DEPENDENCE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; BRAZIL; CANDIDA; CANDIDIASIS, ORAL; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE;

EID: 0034782669     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(01)00290-5     Document Type: Article

References (22)

1. Identification of differentially expressed mRNA tests by an improved display technique (DDRT-PCR)
2. Candida dubliniensis fungemia: The first four cases in North America
3. Candidiasis: The emergence of a novel species. Candida dubliniensis
4. Phylogenetic analysis and rapid identificati6on of Candida dubliniensis based on analysis of ACT1 intron and exon sequences
5. Rapid identification of yeast species using three primers in a polymerase chain reaction
6. Reduced azole susceptibility of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation
7. Identification of Candida dubliniensis in a prospective study of patients in the United States
8. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates
9. Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States
10. Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure
11. Prevalence of Candida dubliniensis isolates in a yeast stock collection
12. Correlation of in-vitro susceptibility test results with clinical response: A study of azole therapy in AIDS patients
13. Isolation of Candida dubliniensis from the oral cavity of an HIV-positive child in Brazil
14. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients
15. Candida dubliniensis: An emerging opportunistic pathogen
16. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals
17. Candida dubliniensis: An update
18. Candida dubliniensis sp. nov.: Phenotypic and molecular characterisation of a novel species associated with oral candidosis in HIV-infected individuals
19. Procedures for isolating yeast DNA for different purposes
20. Candida, Cryptococcus and other yeasts of medical importance
21. Isolation of C. dubliniensis from insulin-using diabetes mellitus patients